Skip to content
healthcare.dev
Get a free key

PROCYSBI

NDC 75987-145, Cysteamine bitartrate, granule, delayed release, from Horizon Therapeutics USA, Inc..

Product NDC
75987-145
Status
Listed
Labeler
Horizon Therapeutics USA, Inc.
Dosage form
GRANULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75987-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYSTEAMINE BITARTRATE300 mg/1

Pharmacologic classes

Cystine Depleting Agent [EPC]; Cystine Disulfide Reduction [MoA]

Package NDCNDC-11Package
75987-145-137598701451360 PACKET in 1 CARTON (75987-145-13) / 1 GRANULE, DELAYED RELEASE in 1 PACKET
75987-145-1475987014514120 PACKET in 1 CARTON (75987-145-14) / 1 GRANULE, DELAYED RELEASE in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d3a3ec28-f746-463a-bb92-3bc8826db09e

Use it

Look up 75987-145 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75987-145 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75987-145. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.